Klacid La

Clarithromycin, the active ingredient in Klacid La, is a macrolide presented as an oral dosage form for systemic use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional.

GNH USA supplies Klacid La as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is a macrolide antibiotic that targets bacterial infections of the respiratory tract, skin and gastrointestinal system.

- Community‑acquired pneumonia: eradicates the causative bacteria and improves lung function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and soft‑tissue infections: eliminates pathogenic bacteria and promotes wound healing. - Helicobacter pylori eradication regimens: contributes to bacterial clearance when combined with other agents.

Adverse reactions may occur with clarithromycin therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort. - Taste disturbance: altered or metallic taste.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: rash, swelling, anaphylaxis. - Clostridioides difficile infection: severe colitis with watery diarrhea.

Before initiating clarithromycin, consider the following safety measures. - Liver function assessment: monitor hepatic enzymes in patients with liver disease. - Cardiac monitoring: avoid in patients with known QT prolongation or electrolyte imbalance. - Drug interaction review: evaluate concurrent medications that affect CYP3A4. - Renal adjustment: dose may need modification in severe renal impairment. - Hypersensitivity check: discontinue if signs of allergic reaction appear. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Clarithromycin interacts with several medicines; awareness helps prevent adverse events.

Major Interactions (Avoid): - QT‑prolonging agents (e.g., erythromycin, cisapride): increased risk of arrhythmia. - CYP3A4 substrates (e.g., simvastatin, lovastatin): elevated plasma concentrations. - Warfarin: enhanced anticoagulant effect, risk of bleeding. - Antacids containing aluminum or magnesium: reduce clarithromycin absorption.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced efficacy, consider backup method. - Digoxin: increased serum levels, monitor cardiac function. - Theophylline: higher concentrations may cause toxicity.